Prostate News Archive
29-Mar-2007
Active Biotech Publishes Data Regarding the TASQ Prostate Cancer Project (RedNova)
Active Biotech (ACTI.ST) publishes a new paper* in the next issue of the scientific journal "The prostate", in collaboration with Dr. John T. Isaacs of The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Relationship between body mass index and prostate cancer is complex --- HealthandAge (HealthandAge)
Study shows that obese men are more likely to have prostate screening tests. In the last few years, there has been increased interest in the relationship between obesity and prostate cancer. A Radical Attack On Prostate Cancer (Forbes)
Dendreon's Provenge could be the first drug that uses the immune system to attack cancer. Is it ready for prime time? FDA staff says drug for prostate cancer works (Seattle Post-Intelligencer)
Dendreon Corp.'s Provenge appeared to safely treat prostate cancer in a trial of the first drug designed to stimulate the body's immune system to fight tumors, U.S. regulators said Tuesday.
Back to Prostate News Archive
